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Coagulase-negative staphylococci (CoNS) are members of the normal human skin microflora and are the microorganisms most frequently isolated from clinical samples (Kloos & Bannerman 1994) . CoNS are also the most common microorganisms identified in blood cultures of newborns in neonatal intensive care units (NICUs), causing 40-60% of the cases of bacteraemia (Maayan-Metzger et al. 2000) .
The continued emergence of antimicrobial drug resistance is a serious problem for the antibiotic treatment of patients with staphylococcal infections in the clinic. Studies have reported that 60-85% of Staphylococcus strains isolated from clinical samples are resistant to methicillin (Kuehnert et al. 2006) . The major problem lies in the fact that infections caused by methicillin-resistant Staphylococcus strains are difficult to treat. In some cases, the isolates are only susceptible to glycopeptides and new drugs, such as linezolid, tigecycline, daptomycin and quinupristin/dalfopristin (Critchley et al. 2003 , Otto 2009 ).
The resistance of Staphylococcus species to oxacillin is mediated by the production of a supplemental penicillinbinding protein (PBP 2' or PBP 2a) that has a low affinity for semi-synthetic penicillins. The protein is encoded by the mecA gene and this gene is identical in all Staphylococcus strains. Thus, mecA is a useful molecular marker of oxacillin resistance (Archer & Niemeyer 1994) . The mecA gene is carried on a specific mobile genetic element, called the staphylococcal cassette chromosome mec (SCCmec). So far, 11 SCCmec types have been described in Staphylococcus aureus (IWG-SCC 2009) . SCCmec types I, II and III are the most common in nosocomial isolates of oxacillin-resistant Staphylococcus strains, whereas the other types are characteristic of community-acquired strains. SCCmec type III encodes the largest number of resistance genes and is associated with serious hospital infections (Ito et al. 1999) . In contrast, SCCmec type IV is small, more mobile and carries only genes that regulate the expression of the mecA gene (Ito et al. 2001) .
As phenotypic methods for the detection of oxacillin-resistant -CoNS [or methicillin-resistant CoNS (MRCoNS)] strains may sometimes yield questionable results, molecular tests for the detection of the mecA gene have been proposed. Detection of the mecA gene by polymerase chain reaction (PCR) is the gold standard for the identification of oxacillin-resistant Staphylococcus and SCCmec typing by multiplex PCR permits the characterisation of the Staphylococcus species and the determination of susceptibility to different non-betalactam antibiotics. In this respect, the objective of the present study was to detect and characterise MRCoNS strains in blood cultures of newborns hospitalised in the NICU of the University Hospital, Faculty of Medicinestudy were already isolated and stored in the Collection of Cultures of the Department of Microbiology and Immunology, UN�SP.
One hundred CoNS strains isolated from blood cultures of newborns hospitalised in the NICU of HC-FMB/ UN�SP were studied in the period from 1990-2009. Samples representing the number of hospitalisations each year were randomly selected for the study. Phenotypic identification of the CoNS species was performed using biochemical tests according to the simplified method of Cunha et al. (2004) . PCR-based determination of internal transcribed spacer (ITS) regions was used for genotypic identification as according to Couto et al. (2001) to confirm the phenotypic identification.
Susceptibility to oxacillin was tested by the agar diffusion method using impregnated disks based on the criteria of the Clinical and Laboratory Standards Institute (CLSI 2009). Oxacillin (1 µg) and cefoxitin (30 µg) disks were used. The international reference strains, S. aureus ATCC 25923 (oxacillin susceptible) and ATCC 33591 (oxacillin resistant), were used in all experiments. Screening medium consisting of Mueller-Hinton agar supplemented with 4 µg/mL oxacillin and 4% NaCl was used for the identification of oxacillin-resistant CoNS strains.
Oxacillin resistance was determined by detection of the mecA gene in the CoNS isolates. The primers and PCR conditions described by Murakami et al. (1991) were used for the amplification procedure. SCCmec typing of the MRCoNS strains was performed by multiplex PCR. The primers and PCR conditions described by Oliveira and Lencastre (2002) and modified by Machado et al. (2007) were used for the amplification procedure.
One hundred CoNS strains were isolated from neonatal blood cultures. (Table) .
The CoNS strains studied were isolated from blood cultures of newborns hospitalised in the NICU of HC-FMB between 1990-2009. Thirty-one of these strains were isolated between 1990-1994 and 16 of them (51.6%) were resistant to oxacillin. Twenty-two strains were isolated between 1995-2002 and 14 (63.6%) (Fig. 2) .
The present study evaluated oxacillin resistance among the 100 CoNS strains isolated from blood cultures of newborns in the NICU of HC-FMB. The rate of oxacillin resistance among the CoNS strains isolated between 1990-2009 was 69%. High rates of oxacillin resistance among neonatal CoNS isolates have been reported by Hira et al. (2007) , who observed that 87% of strains were MRCoNS. In a study conducted between 2005-2006 at a hospital in Porto Alegre, Brazil, 27 of the 57 strains identified as MRCoNS were isolated from the neonatal ward (Barreto & Picoli 2008) .
In the present study, 73.2% of the S. epidermidis isolates were resistant to oxacillin. Similar results have been reported by Krediet et al. (2004) , who found that 97% of S. epidermidis isolates from an NICU between 1999-2001 were oxacillin resistant. Although S. epidermidis was the most prevalent CoNS member and had the highest rate of resistance among the MRCoNS species studied, other resistant species were also identified. Oxacillin resistance was detected in 85.7% of S. haemolyticus strains. According to Ferreira et al. (2003) , 96% of S. haemolyticus strains isolated in Brazil are resistant to oxacillin and S. haemolyticus species are the second most prevalent nosocomial MRCoNS. The mecA gene was detected in 28.6% of the S. hominis strains studied here. This species has been associated with high rates of methicillin resistance, as 100% of isolates from an NICU in Spain were methicillin resistant ( Chaves et al. 2005) . The first report of the mecA gene in S. lugdunensis was published by Kawaguchi et al. (1996) , who detected the gene in one of two isolates obtained from a neonatal ward. In the present study, S. lugdunensis was also isolated from two samples and one of the strains was resistant to oxacillin. According to Tee et al. (2003) , the identification of S. lugdunensis is important not only because of the clinical implications of this species as the most aggressive CoNS strain, but also for determination of oxacillin susceptibility so that early treatment with adequate antibiotics can be initiated and good clinical outcome can be guaranteed.
SCCmec typing permitted the differentiation of types I-IV among the oxacillin-resistant CoNS strains studied. SCCmec type I was detected in 24.6% of the oxacillinresistant CoNS strains and type II was found in 4.3% of the strains. SCCmec type III was found in 56.5% of the MRCoNS isolates and was the most prevalent among the species studied. Similar results have been reported in a Brazilian study conducted by Machado et al. (2007) , who characterised MRCoNS species and revealed the presence of SCCmec type I in 28%, type II in 3% and type III in 52% of the strains. Whereas SCCmec type I contains only the mecA resistance gene, type II carries multiple resistance genes and has been associated with strains that began to be prevalent in the 1980s (Ito et al. 2001) . Type III is the largest of the SCCmec types (66,896 bp) and encodes the largest number of resistance genes. This type is found in many hospital pathogens that can cause serious infections (Ito et al. 1999) .
SCCmec type IV was identified in 14.5% of the MRCoNS strains studied. In contrast, Machado et al. (2007) found that only 0.8% of MRCoNS strains carried SCCmec type IV. The smaller number of strains carrying SCCmec type IV, compared with the hospital types, most likely means an increase in its mobility and capacity of transfer between strains (Healy et al. 2004 ), suggesting that diseases caused by clones that carry SCCmec type IV will tend to increase (Machado et al. 2007 ). All strains carrying SCCmec type IV were identified as S. epidermidis and this type was detected in 15% of oxacillin-resistant strains. Types I-III were also found in S. epidermidis at frequencies of 16.7%, 3.3% and 63.3%, respectively. Similar results regarding the distribution of SCCmec among S. epidermidis strains have been reported by Machado et al. (2007) with types I and IV found in 19% and 0.8%, respectively, whereas the percentage of type III was lower (41.8%). These authors did not detect type II in the S. epidermidis strains studied. The oxacillin-resistant S. haemolyticus strains carried SCCmec type I (83.3%) and type II (16.7%). SCCmec type I was detected in S. hominis strains and SCCmec type III was found in S. lugdunensis. These types are characteristic of nosocomial MRCoNS.
Analysis of the present data revealed an increase in the percentage of CoNS strains isolated from blood cultures during the period from 1991-2009. Furthermore, the results identified a predominant SCCmec profile of the oxacillin-resistant CoNS strains isolated from the NICU. There was a prevalence of SCCmec types found in hospital-acquired strains. SCCmec types I, III and IV were detected in MRCoNS isolates throughout the period studied and their proportion showed little variation, whereas type II was only detected in strains isolated between [2003] [2004] [2005] [2006] . The main limiting factor of the study is the uncertainty as to whether the isolates represent true infections, as no clinical data are presented. A certain percentage of isolates most likely represent skin contamination. Nevertheless, the percentage of MRCoNS strains is elevated and represents a matter of concern in terms of infection control practices in the neonatal ward of the HC-FMB.
